These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37365776)

  • 21. Impact of stratification on adverse drug reaction surveillance.
    Hopstadius J; Norén GN; Bate A; Edwards IR
    Drug Saf; 2008; 31(11):1035-48. PubMed ID: 18840023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Covariate adjustment in subgroup analyses of randomized clinical trials: A propensity score approach.
    Yang S; Li F; Thomas LE; Li F
    Clin Trials; 2021 Oct; 18(5):570-581. PubMed ID: 34269087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methods to adjust for misclassification in the quantiles for the generalized linear model with measurement error in continuous exposures.
    Wang CY; Tapsoba Jde D; Duggan C; Campbell KL; McTiernan A
    Stat Med; 2016 May; 35(10):1676-88. PubMed ID: 26593772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lay public's understanding of equipoise and randomisation in randomised controlled trials.
    Robinson EJ; Kerr CE; Stevens AJ; Lilford RJ; Braunholtz DA; Edwards SJ; Beck SR; Rowley MG
    Health Technol Assess; 2005 Mar; 9(8):1-192, iii-iv. PubMed ID: 15763039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regression-based multiple treatment effect estimation under covariate-adaptive randomization.
    Gu Y; Liu H; Ma W
    Biometrics; 2023 Dec; 79(4):2869-2880. PubMed ID: 37700503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evaluation of inverse probability weighting using the propensity score for baseline covariate adjustment in smaller population randomised controlled trials with a continuous outcome.
    Raad H; Cornelius V; Chan S; Williamson E; Cro S
    BMC Med Res Methodol; 2020 Mar; 20(1):70. PubMed ID: 32293286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment allocation strategies for umbrella trials in the presence of multiple biomarkers: A comparison of methods.
    Ouma LO; Grayling MJ; Zheng H; Wason J
    Pharm Stat; 2021 Nov; 20(6):990-1001. PubMed ID: 33759353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose oral vitamin D supplementation and mortality in people aged 65-84 years: the VIDAL cluster feasibility RCT of open versus double-blind individual randomisation.
    Rake C; Gilham C; Bukasa L; Ostler R; Newton M; Peto Wild J; Aigret B; Hill M; Gillie O; Nazareth I; Sasieni P; Martineau A; Peto J
    Health Technol Assess; 2020 Feb; 24(10):1-54. PubMed ID: 32090730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clarifying selection bias in cluster randomized trials.
    Li F; Tian Z; Bobb J; Papadogeorgou G; Li F
    Clin Trials; 2022 Feb; 19(1):33-41. PubMed ID: 34894795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
    Karrison T; Kocherginsky M
    Clin Trials; 2018 Apr; 15(2):178-188. PubMed ID: 29502444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of selection bias in randomised trials.
    Kahan BC; Rehal S; Cro S
    Trials; 2015 Sep; 16():405. PubMed ID: 26357929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Choosing a covariate-adaptive randomization procedure in practice.
    Zagoraiou M
    J Biopharm Stat; 2017; 27(5):845-857. PubMed ID: 28166466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Issues for stratified randomization based on a factor derived from a continuous baseline variable.
    Qu Y
    Pharm Stat; 2011; 10(3):232-5. PubMed ID: 20922820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Planning a method for covariate adjustment in individually randomised trials: a practical guide.
    Morris TP; Walker AS; Williamson EJ; White IR
    Trials; 2022 Apr; 23(1):328. PubMed ID: 35436970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STRATOS guidance document on measurement error and misclassification of variables in observational epidemiology: Part 1-Basic theory and simple methods of adjustment.
    Keogh RH; Shaw PA; Gustafson P; Carroll RJ; Deffner V; Dodd KW; Küchenhoff H; Tooze JA; Wallace MP; Kipnis V; Freedman LS
    Stat Med; 2020 Jul; 39(16):2197-2231. PubMed ID: 32246539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies.
    Kahan BC; Jairath V; Doré CJ; Morris TP
    Trials; 2014 Apr; 15():139. PubMed ID: 24755011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Shiny Balancer - software and imbalance criteria for optimally balanced treatment allocation in small RCTs and cRCTs.
    Grischott T
    BMC Med Res Methodol; 2018 Oct; 18(1):108. PubMed ID: 30326827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A general method for dealing with misclassification in regression: the misclassification SIMEX.
    Küchenhoff H; Mwalili SM; Lesaffre E
    Biometrics; 2006 Mar; 62(1):85-96. PubMed ID: 16542233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of covariate adjustment approaches under model misspecification in individually randomized trials.
    Tackney MS; Morris T; White I; Leyrat C; Diaz-Ordaz K; Williamson E
    Trials; 2023 Jan; 24(1):14. PubMed ID: 36609282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improper analysis of trials randomised using stratified blocks or minimisation.
    Kahan BC; Morris TP
    Stat Med; 2012 Feb; 31(4):328-40. PubMed ID: 22139891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.